An analysis of the antiemetic protection of metoclopramide plus dexamethasone in Chinese patients receiving moderately high emetogenic chemotherapy

European Journal of Cancer Care

Volumn 11, Issue 2, 2002, Pages 108-113

  Molassiotis, A ^a   Mok, T S K ^b   Yam, B M C ^b   Yung, H ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Breast cancer; Chinese; Cyclophosphamide; Doxorubicin; Metoclopramide; Nausea; Vomiting

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; METOCLOPRAMIDE;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHINA; HUMAN; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDY; VOMITING;

ADULT; ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHINA; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; HUMANS; METOCLOPRAMIDE; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDIES; VOMITING;

EID: 0036593914     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2354.2002.00300.x     Document Type: Article

References (24)

1. Andrykowski M.A. & Gregg M.E. (1992) The role of psychological variables in post-chemotherapy nausea: anxiety and expectation. Psychosomatic Medicine 54, 48-58.
2. du Bois A., McKenna C.J., Anderson H., Lahousen M., Kitchener H., Pinter T., Capstick V. & Wilkinson J.R. (1997) A randomised, double-blind, parallel-group study to compare the efficacy and safety of ondansetron (GR38032F) plus dexamethazone with metoclopramide plus dexamethazone in the prophylaxis of nausea and emesis induced by carboplatin chemotherapy. Oncology 54, 7-14.
3. Burish T.G. & Tope D.M. (1992) Psychological techniques for controlling the adverse side effects of cancer chemotherapy: findings from a decade of research. Journal of Pain and Symptom Management 7, 287-301.
4. Campora E., Giudici S., Merlini L., Rubagotti A. & Rosso R. (1994) Ondansetron and dexamethazone versus standard combination antiemetic therapy. A randomized trial for the prevention of acute and delayed emesis induced by cyclophosphamide-doxorubicin chemotherapy and maintenance of antiemetic effect at subsequent courses. American Journal of Clinical Oncology 17, 522-526.
5. Chang C.S., Chen L.T., Huang S.M., Liu S.F., Chen T.P. & Wei T.C. (1997) Comparison of intravenous granisetron with metoclopramide plus dexamethazone in the prevention of nausea and vomiting associated with emetogenic cytotoxic chemotherapy. Kao-Hsiung I Hsueh Ko Hsueh Tsa Chih (Kaohsiung Journal of Medical Sciences) 13, 97-102.
6. Chiara S., Campora E., Simoni C., Confalonieri M., Psilogenis M. & Rosso R. (1995) Prevention of delayed emesis with metoclopramide and dexamethazone in patients receiving moderately emetogenic cytotoxic treatment. Anticancer Research 15, 1597-1599.
7. Cleri L.B., Kris M.G., Tyson L.B., Pisters K.M., Clark R.A. & Gralla R.J. (1995) Oral combination antiemetics in patients with small cell lung cancer receiving cisplatin or cyclophosphamide plus doxorubicin. Cancer 76, 774-778.
8. Gez E., Warner-Efraty E., ben-Yosef R., Ben-Baruch N., Yitzhaki N., Uziely B., Brufman G. & Biran S. (1987) High-dose metoclopramide and dexamethazone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Oncology 44, 237-239.
9. Italian Group on Antiemetic Research (1994a) Ondansetron plus dexamethasone versus metoclopramide plus dexamethasone plus diphenhydramine in cisplatin-treated patients with ovarian cancer. Supportive Care in Cancer 2, 167-170.
10. Italian Group on Antiemetic Research (1994b) Cisplatin-induced delayed emesis: patterns and prognostic factors during three subsequent cycles. Annals of Oncology 5, 585-589.
11. Italian Group on Antiemetic Research (1997) Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. Journal of Clinical Oncology 15, 124-130.
12. King C.R. (1997) Nonpharmacologic management of chemotherapy-induced nausea and vomiting. Oncology Nursing Forum 24 (Suppl. 7), 41-48.
13. Levitt M., Warr D., Yelle L., Rayner H.L., Lofters W.S., Perrault D.J., Wilson K.S., Latreille J., Potvin M. & Warner E. (1993) Ondansetron compared with dexamtethazone and metoclopramide as antiemetics in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and fluorouracil. New England Journal of Medicine 328, 1981-1084.
14. Madej G., Krzakowski M., Pawinski A., Lasota W., Rogowski W. & Skoneczna I. (1994) A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethazone and metoclopramide in cisplatin-treated patients under conditions of severe emesis. Seminars in Oncology 21 (5 Suppl. 9), 3-6.
15. Malik I., Moid I., Khan Z. & Hussain M. (1999) Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. American Journal of Clinical Oncology 22, 126-130.
16. Martin M. (1996) The severity and patterns of emesis following different cytotoxic agents. Oncology 53 (Suppl. 1), 26-31.
17. Morrow G.R. (1984) The assessment of nausea and vomiting: past problems, current issues, and suggestions for future research. Cancer 53, 2267-2278.
18. Poon R.T. &. Chow L.W. (1998) Comparison of antiemetic efficacy of granisetron and Ondansetron in Oriental patients: a randomised crossover study. British Journal of Cancer 77, 1683-1685.
19. Roila F. (1993) Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination. Oncology 50, 163-167.
20. Roila F., Basurto C., Bracarda S., Sassi M., Iupattelli M., Picciafuoco M., Boschetti E., Tonato M. &. Del Favero A. (1991) Double-blind crossover trial of single vs. divided dose of metoclopramide in a combined regimen for treatment of cisplatin-induced emesis. European Journal of Cancer 27, 119-121.
21. Tsavaris N., Tsarouch-Noutsou E., Bacoyannis C., Mylonakis N., Valilis P., Kozatsani-Halividi D., Tsoutsos H., Droufakou S. &. Kosmidis P. (1992) Antiemetic efficacy of high-dose metoclopramide and dexamethasone in patients receiving cisplatin chemotherapy: a randomized trial. Oncology 49, 479-483.
22. Wang J.Y. (1983) Psychosomatic illness in the Chinese cultural context. In: Romanucci-Ross, L., Moerman, D.E. &. Tancredi, L.R., eds. The Anthropology of Medicine. From Culture to Methods. Praeger, JF Bergin.
23. Wickham R. (1997) Nausea and vomiting: are they still a problem?. In: Gates, R.A., &. Fink, R.M., eds. Oncology Nursing Secrets. Hanley & Belfus, Philadelphia, pp. 250-261.
24. Zhou J., Zeng W. &. Zhang P. (1995) The role of Ondansetron in the prevention of cisplatin-induced vomiting-a randomized clinical trial (in Chinese). Chung-Hua Chung Liu Tsa Chih (Chinese Journal of Oncology) 17, 215-218.